METFORD SR Tablet METFORD SR Tablet METFORD SR Tablet
METFORD SR Tablet

मेटफोर्ड एसआर टैबलेट

उत्पाद विवरण:

  • सामग्रियां मेटफार्मिन
  • भौतिक रूप टेबलेट्स
  • खुराक 1000 मिलीग्राम
  • खुराक संबंधी दिशा-निर्देश निर्देश के अनुसार
  • स्टोरेज निर्देश सूखी और ठंडी जगह रखें
  • अधिक देखने के लिए क्लिक करें
X

मेटफोर्ड एसआर टैबलेट मूल्य और मात्रा

  • 10
  • स्ट्रिप/स्ट्रिप्स
  • स्ट्रिप/स्ट्रिप्स

मेटफोर्ड एसआर टैबलेट उत्पाद की विशेषताएं

  • 1000 मिलीग्राम
  • टेबलेट्स
  • सूखी और ठंडी जगह रखें
  • निर्देश के अनुसार
  • मेटफार्मिन

मेटफोर्ड एसआर टैबलेट व्यापार सूचना

  • वेस्टर्न यूनियन
  • 100 प्रति दिन
  • 7 दिन
  • अफ्रीका एशिया दक्षिण अमेरिका पश्चिमी यूरोप मिडल ईस्ट ऑस्ट्रेलिया मध्य अमेरिका उत्तरी अमेरिका पूर्वी यूरोप

उत्पाद वर्णन

Product details

Composition

METFORMIN

Brand

JOHNLEE

Packaging Type

Strips

Dose

1000 MG

Packaging Size

10 TABS

Dosage Form

Tablets

Company Name: Dhritee Impex

Service Description for METFORD 1000 SR:

सभी उत्पाद देखने के लिए क्लिक करें Dhritee Impex, your trusted partner in health and wellness. We are delighted to present METFORD 1000 SR, a pharmaceutical product designed to empower individuals in the management of diabetes and promote a healthier lifestyle.

About METFORD 1000 SR:METFORD 1000 SR is a state-of-the-art medication formulated with Metformin Hydrochloride, a widely recognized and effective oral antidiabetic agent. Specifically designed for sustained-release, METFORD 1000 SR plays a pivotal role in controlling blood glucose levels in individuals with type 2 diabetes.

Key Features:

  1. Sustained-Release Formula: METFORD 1000 SR employs a sustained-release mechanism, ensuring a gradual and prolonged release of Metformin. This feature contributes to better blood sugar control throughout the day, with fewer fluctuations.

  2. Blood Glucose Regulation: The active ingredient, Metformin Hydrochloride, works by reducing glucose production in the liver and enhancing insulin sensitivity. This dual mechanism aids in the effective regulation of blood glucose levels.

  3. Cardiometabolic Benefits: METFORD 1000 SR has been associated with various cardiometabolic benefits, including improvements in lipid profiles and potential cardiovascular risk reduction in individuals with diabetes.

  4. Weight-Neutral: Unlike some other diabetes medications, METFORD 1000 SR is considered weight-neutral or may even be associated with weight loss in some cases. This makes it a favorable choice for those concerned about weight management.

  5. Patient-Friendly Dosage: The sustained-release formulation allows for once-daily dosing, promoting patient adherence and convenience. The extended-release profile minimizes the likelihood of gastrointestinal side effects.

Why Choose Dhritee Impex:

  1. Commitment to Quality: Dhritee Impex is dedicated to providing pharmaceutical products of the highest quality. METFORD 1000 SR undergoes rigorous quality control processes to ensure safety and efficacy.

  2. Holistic Diabetes Management: Our mission is to support individuals in managing diabetes comprehensively. METFORD 1000 SR is part of our commitment to offering solutions that address the multifaceted aspects of diabetes care.

  3. Expert Guidance: Our team of healthcare professionals is available to offer expert guidance and support. Whether you have questions about METFORD 1000 SR or need advice on diabetes management, we are here to assist you.

  4. Efficient Delivery सेवाएं: Dhritee Impex understands the importance of timely access to medications. Our efficient delivery services ensure that you receive your METFORD 1000 SR when you need it.

Choose Dhritee Impex for your diabetes management needs. METFORD 1000 SR reflects our dedication to providing advanced and patient-centric solutions for a healthier and more vibrant life.

Tell us about your requirement
product

Price:  

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
+91
  • India (भारत)+91
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United States+1
  • China (中国)+86
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1684
  • Andorra+376
  • Angola+244
  • Anguilla+1264
  • Antigua and Barbuda+1268
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1242
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1246
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1441
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1284
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1345
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1767
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1473
  • Guadeloupe+590
  • Guam+1671
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1876
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • Macedonia (FYROM) (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1664
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1670
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1869
  • Saint Lucia+1758
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1784
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1721
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Swaziland+268
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1868
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1649
  • Tuvalu+688
  • U.S. Virgin Islands+1340
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
मोबाइल number

Email

Pharmaceutical Tablets अन्य उत्पाद



Back to top